Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer: A Randomized Clinical Trial

IMPORTANCE: Several studies have explored the efficacy and toxic effects of concurrent 5-fluorouracil (5-FU)– or capecitabine-based chemoradiotherapy (CRT) with or without oxaliplatin in the neoadjuvant setting. Addition of oxaliplatin to 5-FU or capecitabine elicited similar outcomes but with signi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ning, Zhu, Yuan, Liu, Lu-Ying, Feng, Yan-Ru, Wang, Wen-Ling, Wang, Jun, Wang, Hao, Li, Gao-Feng, Tang, Yuan, Hu, Chen, Liu, Wen-Yang, Ren, Hua, Wang, Shu-Lian, Wang, Wei-Hu, Song, Yong-Wen, Liu, Yue-Ping, Fang, Hui, Tang, Yu, Lu, Ning-Ning, Chen, Bo, Qi, Shu-Nan, Liu, Xin-Fan, Li, Ye-Xiong, Jin, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634060/
https://www.ncbi.nlm.nih.gov/pubmed/34846525
http://dx.doi.org/10.1001/jamanetworkopen.2021.36116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634060/
https://www.ncbi.nlm.nih.gov/pubmed/34846525
http://dx.doi.org/10.1001/jamanetworkopen.2021.36116

Ejemplares similares